Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
11.93
+0.09 (0.76%)
Apr 30, 2025, 3:04 PM CST
SHE:300452 Revenue
Anhui Sunhere Pharmaceutical Excipients had revenue of 247.87M CNY in the quarter ending March 31, 2025, with 4.28% growth. This brings the company's revenue in the last twelve months to 892.76M, up 7.66% year-over-year. In the year 2024, Anhui Sunhere Pharmaceutical Excipients had annual revenue of 882.57M with 5.16% growth.
Revenue (ttm)
892.76M
Revenue Growth
+7.66%
P/S Ratio
3.11
Revenue / Employee
921.32K
Employees
969
Market Cap
2.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 882.57M | 43.31M | 5.16% |
Dec 31, 2023 | 839.26M | 134.73M | 19.12% |
Jan 1, 2023 | 704.53M | 87.82M | 14.24% |
Dec 31, 2021 | 616.71M | 85.51M | 16.10% |
Dec 31, 2020 | 531.20M | 67.13M | 14.47% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |